Nigel G. Cooke

1.2k total citations
17 papers, 877 citations indexed

About

Nigel G. Cooke is a scholar working on Molecular Biology, Organic Chemistry and Biochemistry. According to data from OpenAlex, Nigel G. Cooke has authored 17 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Organic Chemistry and 3 papers in Biochemistry. Recurrent topics in Nigel G. Cooke's work include Carbohydrate Chemistry and Synthesis (5 papers), Sphingolipid Metabolism and Signaling (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Nigel G. Cooke is often cited by papers focused on Carbohydrate Chemistry and Synthesis (5 papers), Sphingolipid Metabolism and Signaling (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Nigel G. Cooke collaborates with scholars based in Switzerland, United Kingdom and United States. Nigel G. Cooke's co-authors include Yoji Sakito, Stephen Hanessian, Klaus Hinterding, Rainer Albert, Raymond Baker, Markus Streiff, Christian Beerli, Frédéric J. Zécri, Christian Bruns and Danilo Guerini and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

Nigel G. Cooke

17 papers receiving 848 citations

Peers

Nigel G. Cooke

IMMUN

PFM

ONCOL

Sun‐Young Han South Korea

Susan Cornell-Kennon United States

Roland Feifel Switzerland

Mark R. Swingle United States

Eric T. Sun United States

Elizabeth Keech United Kingdom

Gavin C. Hirst United States

Nadège Loaëc France

Steven Magnuson United States

Toshiya Tamura Japan

Sun‐Young Han South Korea

Nigel G. Cooke

866 ×1.6

307 ×1.0

86 ×0.8

IMMUN

77 ×1.2

PFM

220 ×3.4

ONCOL

Citations per year, relative to Nigel G. Cooke Nigel G. Cooke (= 1×) peers Sun‐Young Han

Countries citing papers authored by Nigel G. Cooke

Since Specialization

Citations

This map shows the geographic impact of Nigel G. Cooke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel G. Cooke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel G. Cooke more than expected).

Fields of papers citing papers by Nigel G. Cooke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel G. Cooke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel G. Cooke. The network helps show where Nigel G. Cooke may publish in the future.

Co-authorship network of co-authors of Nigel G. Cooke

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel G. Cooke. A scholar is included among the top collaborators of Nigel G. Cooke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel G. Cooke. Nigel G. Cooke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Carcache, David A., Anna Vulpetti, Joerg Kallen, et al.. (2018). Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model. Journal of Medicinal Chemistry. 61(15). 6724–6735. 18 indexed citations

Hoegenauer, Klemens, Nicolas Soldermann, Frédéric J. Zécri, et al.. (2017). Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors. ACS Medicinal Chemistry Letters. 8(9). 975–980. 84 indexed citations

Hall, Roger G., Ian C. Bruce, Nigel G. Cooke, et al.. (2017). Investigating the Structure–Activity Relationship of the Insecticidal Natural Product Rocaglamide. CHIMIA International Journal for Chemistry. 71(12). 845–845. 2 indexed citations

Pan, Shifeng, Nathanael S. Gray, Wenqi Gao, et al.. (2013). Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator. ACS Medicinal Chemistry Letters. 4(3). 333–337. 130 indexed citations

Wagner, Jürgen, Peter Matt, Bernard Faller, et al.. (2011). Structure–Activity Relationship and Pharmacokinetic Studies of Sotrastaurin (AEB071), a Promising Novel Medicine for Prevention of Graft Rejection and Treatment of Psoriasis. Journal of Medicinal Chemistry. 54(17). 6028–6039. 33 indexed citations

Zécri, Frédéric J., Rainer Albert, Gregory A. Landrum, et al.. (2009). Pyrazole derived from (+)-3-carene; a novel potent, selective scaffold for sphingosine-1-phosphate (S1P1) receptor agonists. Bioorganic & Medicinal Chemistry Letters. 20(1). 35–37. 6 indexed citations

Wagner, Jürgen, Peter Matt, Richard Sedrani, et al.. (2009). Discovery of 3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a Potent and Selective Inhibitor of Protein Kinase C Isotypes. Journal of Medicinal Chemistry. 52(20). 6193–6196. 104 indexed citations

Thoma, Gebhard, Christian Beerli, Marc Bigaud, et al.. (2008). Reduced cardiac side-effect potential by introduction of polar groups: Discovery of NIBR-1282, an orally bioavailable CCR5 antagonist which is active in vivo. Bioorganic & Medicinal Chemistry Letters. 18(6). 2000–2005. 9 indexed citations

Pan, Shifeng, Yuan Mi, Charles Pally, et al.. (2006). A Monoselective Sphingosine-1-Phosphate Receptor-1 Agonist Prevents Allograft Rejection in a Stringent Rat Heart Transplantation Model. Chemistry & Biology. 13(11). 1227–1234. 108 indexed citations

10.

Albert, Rainer, Klaus Hinterding, Volker Brinkmann, et al.. (2005). Novel Immunomodulator FTY720 Is Phosphorylated in Rats and Humans To Form a Single Stereoisomer. Identification, Chemical Proof, and Biological Characterization of the Biologically Active Species and Its Enantiomer. Journal of Medicinal Chemistry. 48(16). 5373–5377. 116 indexed citations

11.

Dobler, Markus, Ian C. Bruce, Fredrik Cederbaum, et al.. (2001). Total synthesis of (±)-rocaglamide and some aryl analogues. Tetrahedron Letters. 42(47). 8281–8284. 59 indexed citations

12.

Bruce, Ian C., Nigel G. Cooke, Louis J. Diorazio, Roger G. Hall, & Ed Irving. (1999). Synthesis of the carbocyclic analogue of (±)-Rocaglamide. Tetrahedron Letters. 40(22). 4279–4282. 10 indexed citations

13.

Ong, Jennifer, David I.B. Kerr, H. Bittiger, et al.. (1998). Morpholin-2-yl-phosphinic acids are potent GABAB receptor antagonists in rat brain. European Journal of Pharmacology. 362(1). 27–34. 14 indexed citations

14.

Cooke, Nigel G., et al.. (1992). D-xylofuranose: Conversion to its' 3,5-oxetane via an unusual reductive displacement of phthalimide and subsequent regioselective ring opening.. Tetrahedron. 48(43). 9553–9560. 9 indexed citations

15.

Hanessian, Stephen, et al.. (1990). The total synthesis of (+)-ionomycin. Journal of the American Chemical Society. 112(13). 5276–5290. 106 indexed citations

16.

Baker, Raymond, Nigel G. Cooke, Guy R. Humphrey, Stanley H. B. Wright, & Jordan Hirshfield. (1987). Stereoselective synthesis of the dihydrobenzo[b]furan segments of the ephedradine alkaloids. Journal of the Chemical Society Chemical Communications. 1102–1102. 14 indexed citations

17.

Baker, Raymond, Miguel Borges, Nigel G. Cooke, & Richard H. Herbert. (1987). Identification and synthesis of (Z)-(1′S,3′R,4′S)(–)-2-(3′,4′-epoxy-4′-methylcyclohexyl)-6-methylhepta-2,5-diene, the sex pheromone of the southern green stinkbug, Nezara viridula(L.). Journal of the Chemical Society Chemical Communications. 414–416. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact